Risk factor
Meaningful price volatility
Profitability factor
Greatly overvalued vs peers
About
HySum Flexibles Global, Inc. operates as a manufacturer, distributor, and international exporter of packaging solutions, with a primary focus on the pharmaceutical sector. The company's reach extends throughout China and into global markets. Its extensive catalog for pharmaceutical packaging features products such as cold-form and tropical foils, PVC/Aclar sheets, PTP lidding, and a variety of "hipack" offerings like child-resistant packaging, AL/PE strip packs, complex laminated flexible films, and AL/PE suppository laminates. Additional items include lamination foil and pouches, composite films, PVC, PVDC/PVC pharmaceutical packaging, PE series bags, and bottles crafted from PP, PE, and COP materials. Beyond pharmaceuticals, HySum also caters to the food industry, supplying three-layer co-extruded PE films, high-barrier films produced via top-blown and bottom-blown multi-layer co-extrusion, and multi-layer co-extruded sheets. The company further supports the new energy material sector with specialized aluminum plastic films. Its precision injection packaging division delivers products such as precision injection molded packaging, desiccant combinations, exact dosing devices, diagnostic reagent packages, and both plastic and high-barrier vaccine vials. Established in 2005, the company was formerly known as Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. It officially rebranded to HySum Flexibles Global, Inc. in January 2024. The corporate headquarters are situated in Shanghai, China.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is overvalued on EV/EBITDA, reasonably priced o